Our  leadership


LARA BARGHOUT  President & Chief Executive Officer

Lara Barghout joined ReCor Medical in January 2023.

Ms. Barghout brings over 20 years of experience in the medical device industry, leading global organizations and driving cultural transformation, with a particular focus on commercialization, operations and customer service. Most recently, Ms. Barghout served as Senior Vice President and Head of Advanced Therapies at Siemens Healthineers, leading the image-guided therapy business in North America, with focus on unique value-added and integrated solutions and services. Prior to Siemens Healthineers, Ms. Barghout served as Senior Vice President Global Commercial Operations at Terumo Cardiovascular. Throughout her tenure, she oversaw market access, commercial excellence, strategy and commercial operations both regionally and globally. Ms. Barghout holds a Bachelor of Science from Jordan University of Science and Technology and has an MBA from the University of Michigan Ross School of Business Executive Program.


MICHAEL JONES  Chief Financial Officer

Michael Jones joined ReCor Medical in June 2023.

Michael has over 25 years of finance leadership experience across several industries, including medical devices, software, global manufacturing, internet and telecommunications. His expertise is in organizational development, process improvement, and scalability, as evidenced by his prior role as CFO of Sense Biodetection, where he helped them develop infrastructure and ramp up manufacturing in preparation for US Commercialization. Prior to that, he was VP of Finance at Cytek Biosciences, where he led them through a successful IPO in July of 2021. In previous roles, Michael was the Divisional CFO of the Varian Medical Systems Oncology Business Unit; the Corporate Controller at Hitachi Global Storage Technologies; and Controller for the Americas at Yahoo. Michael has an undergraduate degree in Accounting from Tulane University, as well as an MBA from the University of Louisiana at Lafayette.


NEIL C. BARMAN, MD   Chief Scientific Officer

Neil Barman joined ReCor Medical in November 2017.

Prior to joining ReCor, Dr. Barman co-founded AblaCare, a start-up medical device company focused on infertility due to polycystic ovary syndrome. Prior to this, Dr. Barman was an early employee and part of the senior management team at Ardian. Ardian pioneered the field of catheter-based renal denervation and was acquired by Medtronic in January 2011. Previously, Dr. Barman led the clinical/medical team at Concentric Medical that developed the first FDA approved line of embolectomy catheters for ischemic stroke. He started his medical device career at Radiant Medical investigating catheter-based cooling for heart attack and stroke. Dr. Barman graduated Phi Beta Kappa with a B.S. in Biology from Stanford University. He earned his M.D. from Northwestern University Medical School. During medical school, Dr. Barman also did coursework at the Kellogg School of Management.


RICK FELLER Chief Operating Officer

Rick Feller joined ReCor Medical in March of 2022.

Mr. Feller brings over 20 years of leadership experience in medical device development specifically in the areas of R&D, manufacturing development, clinical research, and program management. He began his professional career with Cordis where he led the development of many peripheral interventional products from early-stage concepts through PMA approval. He later expanded his leadership as V.P. of R&D and Manufacturing Development for ev3 in the development of interventional devices treating both peripheral arterial and venous disease. Through subsequent acquisitions by Covidien and then Medtronic, he expanded his responsibilities to manage a global R&D team across the United States and Europe. He later joined Wright Medical as V.P. of R&D and Clinical Research for their shoulder arthroplasty business until an acquisition by Stryker. Mr. Feller is a graduate of the University of Florida with a BS and MS in Materials Science & Engineering.


RYAN BYARS  General Manager, North America

Ryan Byars joined ReCor Medical in May 2023.

Mr. Byars brings over 20 years of experience in the medical device industry in various commercial and operational leadership roles. The majority of his experience is in the field of Interventional Cardiology, and he has led commercial sales teams for both Boston Scientific and Biotronik Vascular in the United States. Mr. Byars has led efforts in sales execution, therapy development, operations, strategy and business development. His leadership brings a focus on coaching, development, and cultural integration to build high performing teams and organizational fortitude. Mr. Byars is a graduate from the University of Kansas with a Bachelor of Science degree in Business Administration and Chemistry.


UDO SCHEINER  VP & GM, Europe, Middle East, and Africa (EMEA)

Udo Scheiner joined ReCor Medical in January 2022.

Mr. Scheiner brings over 20 years of broad commercial and operational experience within the Medical Device Industry. He has lived and worked in several countries across Europe and Asia Pacific. Mr. Scheiner served in various sales, marketing, therapy development and GM roles with increasing scope and responsibility at Guidant in Europe. Following Guidant, Mr. Scheiner held several senior leadership positions at Boston Scientific Corp in Europe and Asia, where he finally served as Regional Vice President of the Asia Pacific region. He then joined Abbott Vascular as Divisional Vice President for the EMEA region before accepting the role of CEO at New Valve Technology (NVT), a start-up company in the structural heart space. Mr. Scheiner is a former Board Member and Chair of the Cardiovascular Sector Group at Eucomed, the European Medical Device Industry Association. He holds a BS degree in Business Management and Engineering from the University of Applied Sciences in Würzburg, Germany.


DAVID KIM  Vice President, Quality Affairs

David Kim joined ReCor Medical in June 2015.

Mr. Kim has 20 years experience with increasing responsibility in quality assurance systems and engineering. Mr. Kim began his quality career at Perclose following the acquisition by Abbott Laboratories, where he lead the site implementation of corporate quality and compliance directives. Following that experience, he worked at several rapidly growing medical device companies including Conor MedSystems where he was part of evolving the quality system to meet the demands of an expanding organization while maintaining a collaborative and innovative culture of compliance. More recently, Mr. Kim has been the first quality employees at several early stage companies including Moximed and Altura Medical, where he was responsible for rapidly establishing the quality system and obtaining ISO certification. Mr. Kim is a graduate of the University of Southern California with a Bachelor of Science in Biomedical Engineering.


JIAYU CHEN, Ph.D  Vice President, R&D

Jiayu Chen joined ReCor Medical in November of 2022.

Dr. Chen has over 20 years of engineering and product development leadership experience in the medical device industry. Prior to joining ReCor Medical, he was VP of Engineering and Advanced Technologies at Gynesonics, a start-up medical device company where he led the team developed and commercially launched a real-time intrauterine ultrasound guided RF ablation system for incisionless uterine fibroid treatments. Previously, Dr. Chen was a chief engineer at GE Healthcare where he led global research teams on technology innovation, studying new clinical solutions and creating of new device platforms. Dr. Chen also served as VP of Engineering at U-Systems, a start-up company acquired by GE Healthcare in November 2012, where he led the team developed the first automated breast cancer screening system and imaging workstation from concept to PMA approval. Dr. Chen received his BS in Material Science from Zhejiang University, MS in Mechanical Engineering from Tsinghua University and Ph.D. in Electrical Engineering from Pennsylvania State University.


HELEN REEVE-STOFFER, Ph.D  Vice President, Clinical Affairs

Helen Reeve-Stoffer joined ReCor Medical in June 2013.

Dr. Reeve-Stoffer has more than 15 years of experience of global clinical and Medical Affairs program development in the medical device industry preceded by an additional 9 years in academic research and teaching. Most recently Dr. Reeve-Stoffer served as CRM Clinical Director for New Product Development and Low Voltage platforms for Boston Scientific Inc. where she was responsible for the pre and post-launch clinical evidence and regulatory program strategies. She also held the position of International Director of Medical Affairs and Education at Cameron Health BV and prior to that had several US and International-based clinical positions for Guidant Corporation including project management, technical field support for all study phases and the development of country-specific clinical business strategies. She began her academic career as an Assistant Professor at the University of Minnesota. Dr. Reeve-Stoffer earned her PhD and BSc in Pharmacology at the University of Leeds, Leeds UK.


LESLIE COLEMAN, DVM, MS, DACLAM  Vice President, Regulatory & Medical Affairs

Leslie Coleman joined ReCor Medical in May 2013.

Dr. Coleman has more than 15 years of experience in the medical device industry in medical affairs, preclinical and clinical research, and over 10 years of veterinary medicine. Prior to joining ReCor Medical, Dr. Coleman served as Director, Medical Affairs at Abbott Vascular Structural Heart. Previously, Dr. Coleman was Director, PreClinical Research at Abbott Vascular and Guidant Corporation where she was a key contributor towards numerous research and development projects to treat coronary artery disease. Dr. Coleman has contributed towards the development of several drug eluting stent platforms through PMA submission, FDA Advisory panel meeting and PMA approval. Dr. Coleman received a Doctorate of Veterinary Medicine at the University of California, Davis, a Masters of Science in Toxicology from the Massachusetts Institute of Technology, and is a Diplomate of the American College of Laboratory Animal Medicine.


DARCI TEOBALDI  VP General Counsel

Darci Teobaldi joined ReCor Medical, Inc. in April 2022.

Ms. Teobaldi oversees all legal issues related to the development and implementation of the company’s business strategy, compliance, corporate governance, human resources and general commercial matters. She has two decades of experience advising companies in the life science, consumer, education and medical device sectors. Before joining ReCor Medical, Inc., she was VP and General Counsel for the Specialty Diagnostic Group of Themo Fisher Scientific in Boston Area, and General Counsel of Advanced Bionics in Southern California. Ms. Teobaldi holds a Bachelor of Science in Business Management from San Diego State University, and a J.D. from Pepperdine University.


DAVE HAUGAARD  Vice President, Operations

Dave Haugaard joined ReCor Medical in September 2018.

Mr. Haugaard brings over 20 years of experience in operational leadership in the development and commercialization of innovative Medical Devices for underserved patients. Previously, Mr. Haugaard was Vice President of Operations at Elixir Medical, a start-up coronary drug eluting stent company where he developed and commercially launched numerous bioabsorbable and metallic stent systems. Prior to this, he was Senior Director of Operations at Conor Medsystems, a drug-eluting stent company acquired by Johnson and Johnson in February 2007 and Director of Operations for Broncus Technologies, which developed devices for interventional pulmonology. During his career Mr. Haugaard has led both domestic and international operations teams from development and through commercialization. He received his BS in Mechanical Engineering from Oregon State University.


RICKY ROBINSON  VP, Human Resources


NORIKO TOJO,  Chairman

Noriko Tojo was appointed chairman of the board of directors of ReCor Medical in July 2018.

Mrs. Tojo is President and Representative Director of Otsuka Medical Devices Co., Ltd. and an Executive Director of Otsuka Holdings Co., Ltd., which she joined in 2008, initially as Managing Director in charge of business development. Prior to joining Otsuka, Mrs. Tojo was a Director of Intel Capital in Tokyo, where she focused on advanced technology-related investments. She joined Intel Capital in 2004 from McKinsey & Company, where she was an Engagement Manager advising major Japanese and US corporations on technology strategy and mergers and acquisitions. Mrs. Tojo started her career as an investment banker with Goldman Sachs in Tokyo. Mrs. Tojo holds a Bachelor of Laws (LL.B.) from the University of Tokyo and an MBA from Harvard Business School.


Lara Barghout 

See above in MANAGEMENT.



Kazumichi Kobayashi, R.Ph., is an Executive Deputy President of Otsuka Medical Devices. Co., Ltd., and Advisor of Otsuka Holdings Co., Ltd. Prior to joining Otsuka Holdings, Mr. Kobayashi was on assignment  as Senior Research Fellow to the Office of Pharmaceutical Industry Research (OPIR) at JPMA from April 2012 to March 2015. Prior to OPIR, he was a Senior Vice President and co-head of Otsuka’s Pharmaceutical Business Division as well as head of Clinical Development, Regulatory Affairs, and Quality Assurance at Otsuka Pharmaceutical. Concurrently, he served as CEO of Otsuka Maryland Research Institute and from 2007 as the first CEO of Otsuka Pharmaceutical Development and Commercialization Inc. (Princeton). He joined the Regulatory Affairs Department of Otsuka Pharmaceutical Co., Ltd. in 1982 and became Director for Regulatory Affairs and Quality Assurance in 2000



Part of Otsuka Medical Devices

ReCor Medical became an Otsuka Medical Devices company in 2018.

Otsuka Medical Devices focuses on the global development and commercialization of endovascular devices that provide new therapeutic options in areas where patient needs cannot be met through pharmaceutical or other conventional treatment. Otsuka Medical Devices Co., Ltd. is a subsidiary of Otsuka Holdings Co., Ltd. (www.otsuka.com/en), a leading global healthcare group listed on the Tokyo Stock Exchange (JP 4578).

Contact Us

1049 Elwell Court
Palo Alto, CA 94303
+1 650 542 7700


Office #46, Innovation House, Innovation Way
Discovery Park
Sandwich, Kent CT13 9FF
+44 1304 806862